Ovarian
Collapse Core Gynecologic Oncology Lecture Series

In concert with the Fellowship Program Directors Committee and geared toward young physicians, the Core Gynecologic Oncology Series includes foundational lectures from experts covering all gynecologic cancer disease sites and treatment modalities. This library of lectures will continue to be expanded over time. Please see individual lecture presentations for specific topics and lecturers.

Formats Available: All Content
Original Series Date: August 26, 2012
On-Demand Release Date: Available Now
MORE INFOMORE INFO Core Gynecologic Oncology Lecture Series
Collapse Germline and somatic genetic evaluation in breast and ovarian cancer (Cocktail Part 2)

Please join us for the first webinar of our new series COCKTAIL- Contemporary Ovarian Cancer: Keys to Therapies and Integrated Learning

This 5-part series will include 4 webinars, and a live "Lunch and Learn" session at the 2018 SGO Annual Meeting on Women's Cancer.  Topics covered include:

  • Implementation strategies for genetic testing
  • Differences in currently available testing platforms
  • How to integrate genetic counselors in an environment where these resources are less abundant.

Accreditation:

Joint Accreditation:

 In support of improving patient care, [Insert name of Joint Accredited Provider] is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

This activity has not been submitted to ACPE for Pharmacists credit

AMA Credit Designation Statement - Physicians

This activity is approved for 1.5 AMA PRA Category 1 Credits.™.

ANCC Credit Designation Statement- Nurses

This CE activity is approved for 1.5 ANCC contact hours.

PAs may claim a maximum of Category 1 credits (1.5) for completing this activity.  NCCPA accepts CAMA PRA Category 1 Credits™ from organizaitons accredited by ACCME or a recognized medical society. 

 

Formats Available: Streaming, Live Webcast + Streaming
Original Series Date: January 23, 2018
On-Demand Release Date: Available Now

Approved Credit:
  • ACCME: 1.50 hours AMA PRA Category 1 Credit(s)

  • MORE INFOMORE INFO Germline and somatic genetic evaluation in breast and ovarian cancer (Cocktail Part 2)
    Collapse Targeted Treatment for Ovarian Cancer (Cocktail Part 1)

    Please join us to discuss the indications for PARP inhibitors for ovarian cancer, including maintenance versus treatment. We will explore the role of bevacizumab in ovarian cancer treatment, including platinum sensitive and resistant disease and maintenance. We will delve deeper into novel therapeutics for ovarian cancer, including immunotherapy and antibody drug conjugates.

    JOINT ACCREDITATION

    In support of improving patient care, Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    AMA Credit designation Statement – Physicians This activity is approved for 1.5  AMA PRA Category 1 Credits ™

    ANCC Credit Designation Statement- Nurse This activity is approved for 1.5 ANCC contact hours.

    This activity has not been submitted to ACPE for Pharmacist credit.

    PA's may claim maximum of 1.5 AMA PRA Category 1™ credits for completing this activity.

    Formats Available: Streaming, Live Webcast + Streaming
    Original Series Date: February 15, 2018
    On-Demand Release Date: Available Now

    Approved Credit:
  • ACCME: 1.50 hours AMA PRA Category 1 Credit(s)

  • MORE INFOMORE INFO Targeted Treatment for Ovarian Cancer (Cocktail Part 1)
    Collapse Understanding and Applying Molecular Profiling Tests in Ovarian Cancer (Cocktail Part 3)

    This third installment of the COCKTAIL series will help learners understand and interpret clinical genomic testing and will discuss cases to reveal practical clinical applications of next generation sequencing in ovarian cancer.  In addition, learners will understand some of the novel applications of tumor sequencing currently in development.

    DISCLOSURES

    Dr. Jocelyn Chapman, MD -- No Disclosures at this time.
    Dr. David Quigly, PhD -- No Disclosures at this time.

    JOINT ACCREDITATION

    In support of improving patient care, Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    AMA Credit designation Statement – Physicians This activity is approved for 1.5  AMA PRA Category 1 Credits ™ Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    ANCC Credit Designation Statement- Nurse This activity is approved for 1.5 ANCC contact hours.

    This activity has not been submitted to ACPE for Pharmacist credit.

    PA's may claim maximum of 1.5 AMA PRA Category 1™ credits for completing this activity.
    Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Formats Available: Streaming
    Original Series Date: April 24, 2018

    Approved Credit:
  • ACCME: 1.50 hours AMA PRA Category 1 Credit(s)
  • ANCC: 1.50 hours Contact Hour
  • AAPA: 1.50 hours Category 1 CME

  • MORE INFOMORE INFO Understanding and Applying Molecular Profiling Tests in Ovarian Cancer (Cocktail Part 3)